Ryman announces new Chief Financial Officer

NZX RELEASE

23 June 2025


Ryman announces new Chief Financial Officer

Ryman Healthcare (NZX:RYM) has announced that Rob Woodgate has resigned and will
step down as Chief Financial Officer (CFO) following the company’s Annual Shareholders
Meeting and Matthew Prior has been appointed as CFO effective from 31 July 2025.
CEO Naomi James said “I would like to take this opportunity to thank Rob for his
contribution to the first stage of our business transformation over the last two years. Rob
has played a key role as we successfully reset the balance sheet and has led the transition to
a new auditor and completion of an extensive financial reporting review. These have been
instrumental in improving the resilience of the business and providing investors with
improved transparency and comparability. We wish him every success as he pursues other
opportunities.”
James said “We look forward to welcoming Matthew Prior as our new CFO at the end of
July. Matthew most recently served as CFO and Head of Australia and New Zealand at
Emerald Clinical, where he led the global finance and commercial teams for one of
Australia’s largest clinical research organisations with a significant international presence.”
“Matthew brings extensive experience in consumer and patient facing healthcare companies
and has a proven track record of delivering for shareholders by driving operational
excellence. Matthew’s leadership and deep healthcare expertise will be invaluable as we
reset performance in our existing business and, following our strategy and portfolio review,
return to disciplined growth and realising the full potential of Ryman’s unique portfolio of
assets,” said James.
Before Mr Prior’s role at Emerald Clinical he worked at Virtus Health as CFO and Vice
President of Finance & Commercial Operations - Asia Pacific at Cochlear. Matthew also
brings extensive capital markets experience with his roles as Head of Equities Research -
Australia at Evans and Partners and Head of Healthcare Equities Research - Asia at Bank of
America Merrill Lynch.
“Matthew has been working with the company on a number of our strategic priorities since
March this year and, with Rob committed to remain available to the Company for two
months following the Annual Shareholders Meeting, we are confident in a smooth
transition.”

ENDS

Authorised by:
Morgan Powell
General Counsel

About Ryman:
Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49
retirement villages in New Zealand and Australia. Ryman villages are home to 15,200
residents, and the company employs 7,800 staff.

Contacts:
For investor relations information contact Hayden Strickett, Head of Investor Relations, on
+64 27 303 1132 or hayden.strickett@rymanhealthcare.com

For media enquiries contact Camille Middleditch on +64 28 422 3472 or
camille.middleditch@sandpipercomms.com